TSE:PRN Profound Medical (PRN) Price, Holdings, & News C$9.64 -0.26 (-2.63%) As of 03:59 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartFDA EventsHoldingsNews and TrendsRatings About Profound Medical (TSE:PRN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Profound Medical alerts:Sign Up Key Stats Today's RangeC$9.39▼C$10.0050-Day RangeC$7.79▼C$9.9952-Week RangeC$6.52▼C$12.40Volume9,300 shsAverage Volume15,673 shsMarket CapitalizationC$352.25 millionAssets Under ManagementC$131.70 millionDividend Yield5.91%Net Expense Ratio0.60%Aggregate RatingModerate Buy ETF Overview Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. Read More Profound Medical ExpensesTypePRNIndustrials ETFsEquity ETFsTSE ETFsAll ETFsManagement Fee0.50%0.50%0.57%0.65%0.53%Other Expenses0.14%2.11%0.53%0.14%0.54%Total Expense0.64%1.45%0.75%0.72%0.73%Fee Waiver-0.04%-3.86%-0.67%-0.04%-0.67%Net Expense0.60%0.56%0.63%0.70%0.60% Receive PRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRN ETF News HeadlinesProfound Medical Reports Strong Third-Quarter Growth and Expands U.S. Distribution1 hour ago | tipranks.comProfound Medical Expands U.S. Distribution Through Cook Medical AgreementNovember 3 at 4:50 PM | tipranks.comThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.November 5 at 1:00 AM | Porter & Company (Ad)Profound Medical Taps Cook iMRI Partnership to Expand TULSA-PRO Reach in U.S.October 30, 2026 | tipranks.comProfound Medical Enlists Montel Williams to Amplify Prostate Care AdvocacyOctober 22, 2026 | tipranks.comProfound Medical Highlights New Evidence Supporting TULSA-PROOctober 14, 2026 | tipranks.comSee More Headlines PRN ETF - Frequently Asked Questions How have PRN shares performed this year? Profound Medical's stock was trading at C$10.77 at the beginning of 2026. Since then, PRN stock has decreased by 10.5% and is now trading at C$9.64. How were Profound Medical's earnings last quarter? Profound Medical Corp. (TSE:PRN) announced its quarterly earnings data on Thursday, November, 5th. The company reported C($0.30) earnings per share for the quarter. The business had revenue of C$13.99 million for the quarter. Profound Medical had a negative trailing twelve-month return on equity of 62.45% and a negative net margin of 170.92%. How do I buy shares of Profound Medical? Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Profound Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Profound Medical investors own include CloudMD Software & Services (DOC), FuelCell Energy (FCEL), Air Canada (AC), Canadian Tire (CTC.A), Enbridge (ENB), Finning International (FTT) and Trisura Group (TSU). Fund Details IssuerInvesco Fund NameInvesco DWA Industrials Momentum ETF Tax ClassificationRegulated Investment Company Stock ExchangeTSECurrent SymbolTSE:PRN Inception Date10/12/2006 Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon Webwww.profoundmedical.com Phone647-476-1350Fund Focus Asset ClassEquity BenchmarkDWA Industrials Technical Leaders Index CategorySector FocusIndustrials Development LevelDeveloped Markets RegionNorth America Number of Holdings45 Fund Statistics Assets Under Management$131.70 million Average Daily Volume$18.99 thousand Discount/Premium-0.74% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerSusquehanna Miscellaneous Outstanding Shares36,540,000Beta1.40 Creation Unit50,000 Creation Fee$500.00 Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report Top 10 PRN HoldingsW.W. Grainger (NYSE:GWW)Holding Weight: 5.63%Cintas (NASDAQ:CTAS)Holding Weight: 5.61%Paycom Software (NYSE:PAYC)Holding Weight: 4.35%GE Aerospace (NYSE:GE)Holding Weight: 4.27%Ryder System (NYSE:R)Holding Weight: 4.22%RTX (NYSE:RTX)Holding Weight: 4.10%Wabtec (NYSE:WAB)Holding Weight: 3.78%Clean Harbors (NYSE:CLH)Holding Weight: 3.74%Johnson Controls International (NYSE:JCI)Holding Weight: 3.69%Sanmina (NASDAQ:SANM)Holding Weight: 3.65%Full Holdings DetailsPRN Sector ExposurePRN Industry Exposure This page (TSE:PRN) was last updated on 11/5/2026 by MarketBeat.com Staff. From Our PartnersThe 401k Email 70 Million Investors Might DeleteAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis little-known fund tracks gold and pays out weeklyA little-known $15 fund tied to gold could pay you cash every Friday, no mining stock required. In one rece...Investors Alley | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.